InduPro
InduPro develops protein-proximity platforms and therapeutics that identify and manipulate interactions between cell-surface proteins, including antibody-based modalities that bring proteins together to alter signaling. Its platforms support discovery of therapeutic targets and development of treatments for disease, with the goal of creating next-generation medicines for patients.
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology
- Founded
- 2022
- Type
- Corporation Seattle business license
- Employees
- 11–50
- Registered name
- InduPro Inc Seattle business license
- Stage
- Series B
Is this your organization? Claim it
Stoke Space’s $1B Series E Propels Seattle Metro to $3.5B in VC Funding Across 94 Q3 Deals
Seattle-area VC activity surged in Q3 as Stoke Space led with a $1 billion Series E initial close and the region raised $3.5 billion across 94 deals, its strongest quarter in at least a decade.
InduPro raises $77M Series B, doses first patient in Phase 1 trial of IDP-001 targeting tumor protein pairs
InduPro raised $77 million in Series B financing and has dosed the first patient in a Phase 1 trial of IDP-001, an antibody-drug conjugate that uses the company’s ARRIS platform to target cancer cells by bringing two surface proteins together.
InduPro raises $77M Series B as it doses first patient in Phase 1 lung cancer trial
Seattle- and Cambridge-based biotech InduPro raised $77 million in a Series B to advance its oncology protein-therapeutics pipeline and is dosing the first patient in a Phase 1 trial targeting lung cancer and other solid tumors.
By InduPro
InduPro names Prakash Raman, Ph.D. CEO; Amanda J. Redig, M.D., Ph.D. serves as CMO with deep biopharma backgrounds
This page profiles InduPro's leadership, highlighting CEO Prakash Raman, Ph.D., and CMO Amanda J. Redig, M.D., Ph.D., summarizing their education and extensive biopharma and drug development experience. It emphasizes Raman’s prior roles at Ribon Therapeutics, Flagship Pioneering, and Novartis and his track record in business development, collaborations, and advancing drug candidates to clinical testing.
People
See all 4-
Amanda J. Redig Executive, Chief Medical Officer
-
Amanda Redig Executive, Chief Medical Officer
-
Prakash Raman Executive, CEO
Online
Questions about InduPro
What is InduPro?
induprotx.com
Who are the people behind InduPro?
Seattle Flow lists Amanda J. Redig (Executive, Chief Medical Officer), Amanda Redig (Executive, Chief Medical Officer), Prakash Raman (Executive, CEO) and 1 more at InduPro.
Who invested in InduPro, and how much has it raised?
Members of Seattle Flow see InduPro's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is InduPro based?
InduPro is headquartered in Seattle, WA, US.
When was InduPro founded?
InduPro was founded in 2022.
How many people work at InduPro?
InduPro has 11–50 employees.